As LLMs compete for doctors' attention, some developers say the science of benchmarking their AI tools for safety and ...
New data on American substance use, concerns of a global HIV resurgence, and more health news from Morning Rounds ...
The effects of isolation extend far beyond children’s time in the hospital,” writes medical student Anna Tsioulias.
ProMIS Neurosciences is trying to design a safer amyloid-clearing drug for Alzheimer's. Early results suggest it might be on ...
Allison covers what hot startups are getting up to, and who’s financing them. She is also co-host of the weekly biotech podcast, “The Readout Loud.” You can reach Allison on Signal at AllisonDeAngelis ...
Here are some things STAT will be watching for during Wednesday’s hearing: Health secretary Robert F. Kennedy Jr. and Paul ...
Growing awareness of a painful endocrine disorder now named PMOS is good news for women of color, who have high prevalence ...
Regulators at the FDA have reiterated concerns that Replimmune does not have adequate data to support an approval of its ...
A Trump administration plan to limit visas for graduate student and postdocs to four years is fueling concerns that the U.S.
Together, HHS, the VA, and the DOD form a strong American innovation ecosystem — one that China and other competitors cannot ...
Katie covers the impact of health technology on patients, clinicians, and businesses. Her stories explore the price tag of clinical AI, digital health at the FDA, and the boom in direct-to-consumer ...
I have come to believe that changing a mind is rarely the point. Planting a seed is,” writes nurse-midwife Mara Evans.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results